BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 32246402)

  • 21. Positive regulatory role of c-Src-mediated TRIM25 tyrosine phosphorylation on RIG-I ubiquitination and RIG-I-mediated antiviral signaling pathway.
    Lee NR; Choi JY; Yoon IH; Lee JK; Inn KS
    Cell Immunol; 2018 Oct; 332():94-100. PubMed ID: 30100205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal/Tirap, suppressing LPS-induced inflammatory responses.
    Mitchell J; Kim SJ; Seelmann A; Veit B; Shepard B; Im E; Rhee SH
    Biochem Pharmacol; 2018 Jan; 147():119-127. PubMed ID: 29175418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC).
    Hsu PC; Yang CT; Jablons DM; You L
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32466572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SRC-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin.
    Li H; Lemay S; Aoudjit L; Kawachi H; Takano T
    J Am Soc Nephrol; 2004 Dec; 15(12):3006-15. PubMed ID: 15579503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
    Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered regulation of Src tyrosine kinase by transforming growth factor beta1 in a human hepatoma cell line.
    Fukuda K; Kawata S; Tamura S; Matsuda Y; Inui Y; Igura T; Inoue S; Kudara T; Matsuzawa Y
    Hepatology; 1998 Sep; 28(3):796-804. PubMed ID: 9731575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.
    Yao XQ; Zhang XX; Yin YY; Liu B; Luo DJ; Liu D; Chen NN; Ni ZF; Wang X; Wang Q; Wang JZ; Liu GP
    Biochem J; 2011 Jul; 437(2):335-44. PubMed ID: 21554241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross talk between beta-adrenergic and bradykinin B(2) receptors results in cooperative regulation of cyclic AMP accumulation and mitogen-activated protein kinase activity.
    Hanke S; Nürnberg B; Groll DH; Liebmann C
    Mol Cell Biol; 2001 Dec; 21(24):8452-60. PubMed ID: 11713280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
    Sachsenmaier C; Sadowski HB; Cooper JA
    Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease in coupling of Gs in v-src-transformed NIH-3T3 fibroblasts: possible involvement of tyrosine phosphorylation of Gs by pp60v-src.
    Akiho H; Tokumitsu Y; Noda M; Nomura Y
    Arch Biochem Biophys; 1993 Jul; 304(1):235-41. PubMed ID: 7686735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense src expression inhibits tyrosine phosphorylation of Shc and its association with Grb2 and Sos which leads to MAP kinase activation in U937 human leukemia cells.
    Yamaguchi M; Tanaka T; Waki M; Kitanaka A; Kamano H; Kubota Y; Ohnishi H; Takahara J; Irino S
    Leukemia; 1997 Apr; 11(4):497-503. PubMed ID: 9096689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Src activation by β-adrenoreceptors is a key switch for tumour metastasis.
    Armaiz-Pena GN; Allen JK; Cruz A; Stone RL; Nick AM; Lin YG; Han LY; Mangala LS; Villares GJ; Vivas-Mejia P; Rodriguez-Aguayo C; Nagaraja AS; Gharpure KM; Wu Z; English RD; Soman KV; Shahzad MM; Zigler M; Deavers MT; Zien A; Soldatos TG; Jackson DB; Wiktorowicz JE; Torres-Lugo M; Young T; De Geest K; Gallick GE; Bar-Eli M; Lopez-Berestein G; Cole SW; Lopez GE; Lutgendorf SK; Sood AK
    Nat Commun; 2013; 4():1403. PubMed ID: 23360994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
    Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
    Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.
    Park JS; Choi HI; Kim DH; Kim CS; Bae EH; Ma SK; Kim SW
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Role of Src in Priming Pyk2 Phosphorylation.
    Zhao M; Finlay D; Zharkikh I; Vuori K
    PLoS One; 2016; 11(2):e0149231. PubMed ID: 26866924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of the mammalian Hippo signaling pathway.
    Ji XY; Zhong G; Zhao B
    Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation.
    Aznar S; Valerón PF; del Rincon SV; Pérez LF; Perona R; Lacal JC
    Mol Biol Cell; 2001 Oct; 12(10):3282-94. PubMed ID: 11598209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential role of YAP in Axl-mediated resistance to EGFR tyrosine kinase inhibitors.
    Saab S; Chang OS; Nagaoka K; Hung MC; Yamaguchi H
    Am J Cancer Res; 2019; 9(12):2719-2729. PubMed ID: 31911857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.